You don't need to figure this out through expensive trial and error
The most studied mechanisms include: upregulation of growth hormone receptors in fibroblasts (increasing sensitivity to healing signals), activation of the FAK-paxillin pathway (promoting cell adhesion and migration), modulation of the nitric oxide system through Src-Caveolin-1-eNOS phosphorylation (enhancing vascular function), and dual activation of the Egr-1/NAB2 gene loop (promoting organized, non-chaotic blood vessel growth)
However, efficacy is dependent on renal function, and empagliflozin may be ineffective at reducing glucose levels in patients with this degree of renal impairment
B12 itself doesnt mask other deficiencies, but its possible to have other vitamin deficiencies (like folate or vitamin D) at the same time
My question revolves around SIBO as there is some conflicting info online
It just increases hepatic clearance load and the likelihood of injection site discomfort